View From Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program


As 340B covered entities continue to feel the financial impact of Medicare Part B reimbursement cuts and drug manufacturer actions that limit access to 340B pricing, a new Administration and new Congress will soon be in place. What will this mean for the future of the 340B program?

Join Omnicell for a live virtual event, “View from Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program,” to hear from multiple 340B stakeholders in a lively discussion of the latest industry and legislative developments in 340B—just as the 2021 legislative season gets underway. The session will address:

  • The status of proposed and pending legislative and legal actions
  • Financial implications from Covid-19 loss of business
  • A covered entity’s perspective around strategies for optimizing program performance amidst the ever-changing 340B landscape
  • The future of the 340B program

This live session takes place on Wednesday, Jan. 27 from 10:00 AM–11:00 AM PT | 1:00 PM–2:00 PM ET, and will feature Omnicell 340B’s Jeff Spencer; Ted Slafsky, publisher and CEO of 340B Report; Shrujal Patel, co-founder and managing director of Alinea Group, LLC; and a covered entity guest.

Spots are limited, so register today. 

Website | + posts
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report